Primary Site >> Liver Cancer

Gene >> MCM8

Journal: J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
Title: Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Author: Bird, S M|Goldberg, D J|Hutchinson, S J
PMID: 11437088
Journal: J Virol. 2002 May;76(9):4580-90.
Title: Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors.
Author: Zaiss, Anne-Kathrin|Liu, Qiang|Bowen, Gloria P|Wong, Norman C W|Bartlett, Jeffrey S|Muruve, Daniel A
PMID: 11932423
Journal: Surg Endosc. 2012 Apr;26(4):1108-15.
Title: Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablation.
Author: Santambrogio, Roberto|Costa, Mara|Barabino, Matteo|Zuin, Massimo|Bertolini, Emanuela|De Filippi, Francesca|Bruno, Savino|Opocher, Enrico
PMID: 22044972
Journal: Contemp Clin Trials. 2014 Mar;37(2):301-11.
Title: Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
Author: Scorletti, E|Bhatia, L|McCormick, K G|Clough, G F|Nash, K|Calder, P C|Byrne, C D
PMID: 24556343
Journal: Anat Rec (Hoboken). 2016 Jul;299(7):869-77.
Title: SNF5 is Involved in Suppression of Hepatocellular Carcinoma Progression via TGF-Beta 1 Signaling.
Author: Sun, Hongmiao|Zhong, Xinping|Wang, Chunyu|Wang, Shengli|Lin, Lin|Zou, Renlong|Wu, Yi|Sun, Ning|Sun, Ge|Wen, Tao|Chi, Zhi-Hong|Zhao, Yue
PMID: 27111394
Journal: Rinsho Byori. 2016 May;64(4):472-479.
Title: [Present State of Non-B Non-C Liver Disease-and Its Monitoring.]
Author: Shima, Toshihide|Mizuno, Masayuki|Okanoue, Takeshi
PMID: 29182821
Journal: Anat Rec (Hoboken). 2017 Nov;300(11):1981-1992.
Title: Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Author: Margiotta, Alyssa L|Bain, Lisa J|Rice, Charles D
PMID: 28710803
Journal: BMC Cancer. 2018 Feb 20;18(1):200.
Title: MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
Author: Liu, Zhikun|Li, Jie|Chen, Jun|Shan, Qiaonan|Dai, Haojiang|Xie, Haiyang|Zhou, Lin|Xu, Xiao|Zheng, Shusen
PMID: 29463213